Cell and Gene Therapy 12/12/2018 Advanced Therapy Manufacturing: The Supply Chain Challenge Advanced therapy manufacturing and supply chains are anything but conventional
Cell and Gene Therapy 03/12/2018 Industrializing Advanced Therapies Changing mindsets to drive efficient manufacturing and commercialization of advanced therapies
Cell and Gene Therapy 28/11/2018 Demystifying the Common Technical Document Top tips for completing the common technical document for advanced therapies with Chris Bravery, Consulting Regulatory Scientist, Advanced Biologicals
Cell and Gene Therapy 28/11/2018 The Clinician’s Perspective on Patient Access Two healthcare professionals give their views on delivering advanced therapies in the clinic...
Cell and Gene Therapy 09/11/2018 Understanding Global, Complex Supply Chains for Advanced Therapies A snapshot of the supply chain, logistics and customs challenges for advanced therapies
Cell and Gene Therapy 08/10/2018 FDA Regulatory Reform? An interview with Anthony Davies, Founder and CEO, Dark Horse Consulting
Cell and Gene Therapy 01/10/2018 [INTERVIEW] An Academic Perspective on Cell Therapy, Trial Design... An interview with Dr David Courtman of the Ottawa Hospital, the University of Ottawa and Northern Therapeutics
Cell and Gene Therapy 20/09/2018 60 seconds with...Detlev Parow, DAK-Gesundheit A Payer’s Perspective on CAR-T Pricing and Reimbursement
Cell and Gene Therapy 12/09/2018 The Evolution of Advanced Therapies: A 200-Year History 200 years of milestones and achievements that have led to today's advanced therapies industry
Cell and Gene Therapy 06/09/2018 We’re answering this year’s question with a firm “maybe!” A guest blog from Stacey Johnson, Director, Communications and Marketing at CCRM and Phacilitate:Exchange editorial board member
Cell and Gene Therapy 31/08/2018 WEBINAR: Avoid Tripping at the Last Mile Your therapy is cryopreserved and ready to change a patient's life. Is the cryogenic ecosystem in place to ensure you do not trip at the last...
Cell and Gene Therapy 14/08/2018 Preparing for Commercialisation with the Right CDMO An interview with J. Kelly Ganjei, CEO and Chairman of the Board, Cognate BioServices, Inc
Cell and Gene Therapy 01/08/2018 Building Manufacturing Infrastructure for Cell and Gene Therapies The production shortfall for cell therapies and viral vectors could have a devastating effect on the growth and success of the industry but...
Cell and Gene Therapy 31/07/2018 The Importance of Durability for Anticancer Cell Therapies Cenk Sumen, Director at Thermo Fisher discuss durability of anticancer therapies and its importance in relation to pricing and reimbursement...
Cell and Gene Therapy 24/07/2018 Raman Spectroscopy: A New Analytical Technique to Ensure the... As we see more cell and gene therapies gaining market authorisation, attention is turning to the bioprocesses used for their manufacture,...
